H. G. van der Poel
Papers
1
Total Citations
4
H-Index
1
About
H. G. van der Poel is a leading urologic oncologist whose research focuses on advancing treatment strategies for prostate cancer, particularly in the challenging setting of radiorecurrent disease. His major contributions center on comparing salvage therapies for patients whose cancer recurs after initial radiotherapy—a group with historically poor outcomes. In his seminal 2026 study, van der Poel directly compared salvage focal therapy (sFT) with salvage radical prostatectomy (sRP), demonstrating that sFT can achieve effective cancer control while substantially reducing treatment-related morbidity. This work, already garnering 4 citations, has reshaped clinical decision-making by offering a less invasive alternative for men with localized recurrences. Beyond this landmark paper, van der Poel has been instrumental in refining patient selection criteria for focal therapy and advancing our understanding of prostate cancer recurrence patterns. His research bridges the gap between oncologic efficacy and quality of life, making him a pivotal figure in the evolution of precision prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1